Navigation Links
ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results
Date:11/2/2010

e is ready to launch BROMDAY this month.  We expect to discontinue the twice-daily XIBROM (bromfenac ophthalmic solution)® 0.09% product in early 2011."

Continued Anido, "With our newest product pipeline developments, we have proven our ability to extract significant additional value from our core therapeutic compounds, bromfenac and bepotastine.  In addition to gaining approvals for BROMDAY and BEPREVE™, we initiated our REMURA™ (bromfenac ophthalmic solution for dry eye) Phase 3 clinical program, plus released the positive results of our Phase 1/2 bepotastine besilate nasal spray study.  Based upon these Phase 1/2 results, we plan to submit an Investigational New Drug (IND) Application to the FDA for bepotastine nasal spray to initiate Phase 2 clinical studies before the end of 2010.  In addition, we expect to report the results of the REMURA Phase 3 dry eye efficacy study in the middle of 2011.  Gaining approval for both product candidates would allow us to participate in significantly larger market segments than those for ISTA's current product offerings.  To complement our eye care and allergy franchises, we continue to evaluate acquiring both late-stage drug candidates to add to our pipeline and marketed products to add to our sales portfolio, assets that have the potential to deliver significant value to our stakeholders for years to come."Net Revenues

(In millions, except percentage data)Three Months Ended

September 30,

Nine Months Ended

September 30,2010

2009

Change

2010

2009

ChangeXIBROM

$29.6

$21.4

38%

$71.0

$55.1

29%BEPREVE

3.9

1.2

225%

10.6

1.2

783%ISTALOL

5.3

5.1

4%

15.0

13.0

15%VITRASE

3.2

1.4

129%

8.8

4.0

120%Product sales, net

42.0

29.1

44%

1
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
2. Access Pharmaceuticals Awarded $1.5 Million in Section 48D Grants
3. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
4. Alder Biopharmaceuticals Appoints Bruce Montgomery to Board of Directors
5. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
6. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
7. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
8. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2010 Financial Results on November 5, 2010
9. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2010 Financial Results
10. VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
11. MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX™ in FREEDOM-301 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... ON , March 26, 2015 /PRNewswire/ - Pivotal Therapeutics ... pharmaceutical company with a focus on Omega-3 therapies for ... 25, 2015 it issued 763,752 common shares of the ... of interest for the period of December 5 th ... its outstanding Convertible Notes that is due on or ...
(Date:3/26/2015)... "Whether it,s our family, our friends, all ... In a single sentence, Dr. Anthony Coyle , ... Centers for Therapeutic Innovation (CTI), sums up ... America,s biopharmaceutical companies. CTI,s unique model ... foundations and the National Institutes of Health (NIH) to ...
(Date:3/26/2015)... 2015 Cardiologists at Beaumont Hospital, ... commercial implant of a device recently approved by the ... fibrillation. The Watchman Left Atrial Appendage Closure implant is ... to reduce the risk of stroke. Atrial ... more than 5 million Americans. Twenty percent of all ...
Breaking Medicine Technology:Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3
... International, a leading Clinical Research Organization, will host an ... development on 24 August 2010 at 11:30 am (EDT). ... Scientific Affairs unit, will be the presenter. ... the expensive failures that pharmaceutical companies experience during late-stage ...
... Bulletin Board: WGBS ), a leading developer of ... three and six months ended June 30, 2010.   ... 2010 grew to $432,000 compared to $69,000 for the second ... ended June 30, 2010 grew to $822,000 compared to $111,000 ...
Cached Medicine Technology:PRA International Hosts Audio Conference on CV Drug Development 2WaferGen Reports Second Quarter 2010 Financial Results 2WaferGen Reports Second Quarter 2010 Financial Results 3WaferGen Reports Second Quarter 2010 Financial Results 4WaferGen Reports Second Quarter 2010 Financial Results 5WaferGen Reports Second Quarter 2010 Financial Results 6WaferGen Reports Second Quarter 2010 Financial Results 7
(Date:3/28/2015)... 2015 Rocket Pure , a manufacturer ... release of their new natural sunscreen. They are offering ... Both options come with a bonus lip balm sunscreen. ... on Amazon. Click to see the natural sunscreen ... natural sunscreen is made with non-nano zinc oxide and provides ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 With ... in the fields of osteoporosis, osteoarthritis and musculoskeletal ... Osteoporosis, it may be the first time in ... research forum that the hot-button topic is an ... on the well-accepted scientific principles of Wolff’s law, ...
(Date:3/28/2015)... 2015 An article in Fortune on ... prove critical to organizations that deal with PCI (Payment ... of data security, is worsening . Using numbers ... every major category out of the twelve measured improved, ... all the craziness that has gone on in the ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Delaying rotator ... be necessary, according to research presented today at the ... Specialty Day. , “Our study compared results for 170 ... underwent an additional glenohumeral joint capsule release procedure to ... Murrell MD, PhD, lead author from St. George Hospital ...
(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), ... therapy jobs, has announced that it will participate ... Association Annual Conference to be held April 10-11, ... Columbus, OH. , The OPTA Annual Conference ... products and services. , Representatives from Aureus ...
Breaking Medicine News(10 mins):Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
... have said that sleep would probably help the human brain ... facts.// ,It was reported that previous studies had ... steps of learning to tap numeric sequences on a keyboard. ... declarative memory like those used for recalling the facts for ...
... (MIMS) is planning to launch a chain of satellite hospitals ... of non-resident Indian (NRI) doctors residing in Gulf Cooperation Council ... Kottakal in Malappuram district of the state for the purpose, ... ,MIMS chairman Azad Moopen told the newspaper that the ...
... Zealand Food Safety Authority (NZFSA) has warned people against ... bags are clearly labelled as requiring to be cooked ... is known to sometimes carry norovirus, which causes a ... Korean oysters are packed frozen in 1kg bags and ...
... at the Institute Of Cancer Research have discovered a new ... disease.// ,It is found that if a person ... diagnosed with breast cancer doubles. This would serve as a ... of cancer and thereby help treat and prevent the disease. ...
... differently in the same organs of males and females ... sheds light on why the same disease often strikes ... respond differently to the same drug. ,"We ... vary in their relationship to different diseases," explained Xia ...
... begin before the age of 14 years are not only ... from alcohol until they're 21//, but they also tend to ... with alcohol throughout their lives. ,The study's lead ... of Public Health's Youth Alcohol Prevention Centre said that while ...
Cached Medicine News:Health News:Sleep Essential For A Strong Memory 2Health News:Same Genes Act Differently in Males and Females 2Health News:Same Genes Act Differently in Males and Females 3Health News:Alcoholism & Dependence Seen More Commonly In Early Alcohol Drinkers 2
... Finntips have been designed to optimize the ... of our tip products is widely recognized ... range has been extended over the years ... standard and special tips including filter tips, ...
... optimize the accuracy and precision of Finnpipettes. ... widely recognized by customers throughout the world. ... the years and now covers a full ... filter tips, certified pure tips, stepper tips ...
... The easy way to order tips. Each ... tips)except for D10mL, which contains 200 tips (4 ... re-sealable Bulk Packs of 200 tips per pack. ... which can easily be opened for quick access ...
Conducting disposable tips....
Medicine Products: